Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational Modifications

21 Aug 2023

Abstract excerpt

Cancer involves a series of diseases where cellular growth is not controlled. Cancer is a leading cause of death worldwide, and the burden of cancer incidence and mortality is rapidly growing, mainly in developing countries. Many drugs are currently used, from chemotherapeutic agents to immunotherapy, among others, along with organ transplantation. Treatments can cause severe side effects, including remission and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to Erythrocyte Function and Pathophysiology
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37630415
DOI: 10.3390/molecules28166163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational ModificationsPMID 37630415Read ↗

ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer ControlSemantic proximity Read ↗

Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysisSemantic proximity Read ↗

Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatmentsSemantic proximity Read ↗

The Emerging Roles of the Metabolic Regulator G6PD in Human CancersSemantic proximity Read ↗

Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for CancerSemantic proximity Read ↗

Metabolic reprogramming and disease progression in cancer patients.Semantic proximity Read ↗

Moonlighting functions of glucose metabolic enzymes and metabolites in cancerSemantic proximity Read ↗

Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer.Semantic proximity Read ↗

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.Semantic proximity Read ↗

Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target.Semantic proximity Read ↗

Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug TargetsSemantic proximity Read ↗

Targeting of several glycolytic enzymes using RNA interference reveals aldolase affects cancer cell proliferation through a non-glycolytic mechanism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.